期刊文献+

阿托伐他汀对缺血性脑血管病患者同型半胱氨酸、C反应蛋白及颈动脉内中膜厚度的影响 被引量:8

Effect of Artorvastatin on homocysteine,C-reactive protein and carotid artery intima-media thickness in patients with ischemia cerebrovascular disease
暂未订购
导出
摘要 目的 观察阿托伐他汀对缺血性脑血管病患者同型半胱氨酸(Hcy)、C反应蛋白(CLRP)及颈动脉内中膜厚度(IMT)的影响.方法 将2012年2月~2013年6月入住江门市人民医院神经内科且符合入选标准的患者随机分为两组,A组40例采用201 1年缺血性脑血管疾病治疗指南常规治疗并加用每日20 mg剂量阿托伐他汀,B组40例采用常规治疗并加用每日40 mg剂量阿托伐他汀.对所有患者随访6个月,记录初诊、治疗1、3、6个月时的Hcy及CRP水平,记录初诊及治疗6个月时颈动脉IMT.结果 对于缺血性脑血管病患者合并颈动脉IMT增厚者,阿托伐他汀连续应用1个月可以明显降低Hcy、CRP水平,连续应用6个月可以降低颈动脉IMT,并且B组降低Hcy、CRP及颈动脉IMT的效果较A组更明显,差异有统计学意义(P<0.05),两组的药物不良反应相当.结论 阿托伐他汀可以降低缺血性脑血管病患者Hcy、CRP及颈动脉IMT,并且大剂量组的效果更明显,不良反应相当. Objective To investigate the effect of Atorvastatin on homocysteine (Hcy),C reactive protein (CRP) and carotid artery intima-media thickness (IMT) in patients with ischemic cerebrovascular disease.Methods The patients who met the inclusion criteria at Department of Neurology in the People's Hospital of Jiangmen City from February 2012 to June 2013 were randomly divided into two groups,40 cases in group A (using the 2011 guidelines for the treatment of ischemic cerebral vascular disease,conventional therapy plus Atorvastatin 20 mg daily dose),40 cases in group B (conventional therapy plus 40 mg daily dose of Atorvastatin).All patients were followed up for 6 months,recording of newly diagnosed,treatment for 1 month,3 months and 6 months of Hcy and CRP,the newly diagnosed and treatment of 6 months of the carotid artery IMT.Results For the patients with ischemic cerebral vascular disease and with carotid artery IMT thickening,continuous application of Atorvastatin for 1 month could significantly decrease Hcy,CRP level,continuous use for 6 months could reduce the carotid artery IMT,and the effect was more significant in group B than that in group A in decreasing Hcy,CRP and artery IMT,the differences were statistically significant (P 〈 0.05),adverse drug reactions of the two groups was quite.Conclusion Atorvastatin can reduce Hcy,CRP and carotid artery IMT in patients with ischemic cerebrovascular disease,and the effect of the large dose group is more obvious.The adverse reactions of the two groups are quite.
出处 《中国医药导报》 CAS 2014年第8期79-81,84,共4页 China Medical Herald
基金 广东省江门市第二批科技计划项目(项目编号:江科[2012108号])
关键词 阿托伐他汀 颈动脉内中膜厚度 C反应蛋白 同型半胱氨酸 Atorvastatin Carotid artery intima-media thickness C-reactive protein Homocysteine
  • 相关文献

参考文献17

  • 1Magyar MT,Szikszai Z,Balla J,et al. Early-onset carotid atherosclerosis is assocaited with increased intima-media thickness and elevated serum levels of inflammatory mark- ers [J]. Stroke, 2003,34 : 58-63.
  • 2Biselli PM, Guerzoni AR ,de Godoy MF ,et al. Genetic polymorphisms involved in folate metabolism and concen- trations of methylmalonic acid and folate on plasma homo- cysteine and risk of coronary artery disease [J]. J Throm- bolysis, 2010,29 ( 1 ) : 32.
  • 3McCully KS. Vascular pathology of homocysteinemia :im- plications for the pathogenesis of arteriosclerosis [J]. Am J Patho, 1969,56 ( 1 ) : 111-128.
  • 4董少军,马锐,吴承志.中青年脑梗死患者血清同型半胱氨酸水平与颈动脉硬化的关系[J].蚌埠医学院学报,2009,34(3):209-211. 被引量:16
  • 5戚国庆,刘刚,刘坤申.高同型半胱氨酸与血栓形成性疾病[J].实用心脑肺血管病杂志,2003,11(4):250-252. 被引量:16
  • 6Hashimoto H, Kitagawa K, Hougaku H, et al. Relationship between C-reactive protein and progression of early carotid atherosclerosis in hypertensive subjects [J]. Stroke, 2004,35(7) : 1625-1630.
  • 7Calabro P,Golia E,Yeh ET. CRP and the risk of atheroscle- rotic events [J]. Semin Immunopathol, 2009,31 (1) :79-94.
  • 8唐蕾蕾,黄友敏,李永涛,张涛.急性脑梗死患者颈动脉内膜中层厚度与血浆血管内皮细胞钙黏蛋白、溶血磷脂酸含量的变化[J].中华临床医师杂志(电子版),2009,3(3):76-78. 被引量:10
  • 9Crouse JR,Tang R,Espeland MA ,et al. Associations of extracranial carotid atheroselerosis progression with coro- nary status and risk factors in patients with and without coronary artery disease [J]. Circulation,2002,106(16) :2061- 2066.
  • 10Pradhan AD, Manson JE,Rifai N,et al. C-reactive pro- tein,interleukin-6,and risk of developing type 2 dia- betes mellitus [J]. JAMA, 2001,286 (3) : 327-334.

二级参考文献79

共引文献88

同被引文献76

  • 1各类脑血管疾病诊断要点[J].中华神经科杂志,1996,29(6):379-380. 被引量:33099
  • 2Jiang B,Chen Y,Yao G,et al.Effects of differences in serum total homocysteine,folate,and vitrmin B 12 on cognitive impairment in stroke patients[J].BMC Neurol,2014,14(1):217.
  • 3Anderson JL,Muhlestein JB,Horne BD,et al.Plasma homocysteine predicts mortality independently of traditional risk factors and C-reactive protein in patients with angiographically defined coronary artery disease〔J〕.Circulation,2000,102:1227-1232.
  • 4Garcia-Pinilla JM,Espinosa-Caliani S,Jimenez-Navarro M,et al.Influence of 677 C→T polymorphism of methylenetetrahydrofolate reductase on medium-term prognosis after acute coronary syndromes〔J〕.Tex Heart Inst J,2007,34(2):142-147.
  • 5Varela-Moreiras G.Nutritional regulation of homocysteine:effects of drugs[J].Biomed Pharmacother,2001;55(8):448.
  • 6Olszewski AJ,Mc Cully KS.Homocysteine metabolism and the oxidavite modification of proteins and lipids.Free Radic Biol Med,1993,14:683-93.
  • 7Jakubowski H.Molecular basis of homocysteine toxicity in humans[J].Cell Mol Life Sci,2001,61:470-487.
  • 8Jakubowski H,Goldman E.Synthesis of homocysteine thiolactone by methionyl-tRNA synthetase in cultured mammalian cells[J].FEBS Lett,1993,317:593-598.
  • 9Jakubowski H,Zhang L,Bargeguez A,et al.Homocysteine thiolactone and protein homocysteinylation in human endothelial cells:Implications for atherosclerosis[J].Circ Res,2000,87(1):45-51.
  • 10Jakubowski H.Metabolism of homocysteine thiolactone in human cell cultures:possible mechanism for pathological consequences of elevated homocysteine levels[J].J Biol Chem,1997,272(3):1935-1942.

引证文献8

二级引证文献28

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部